Development, validation, and clinical utility of risk prediction models for cancer-associated venous thromboembolism: A retrospective and prospective cohort study
Open Access
- 23 March 2025
- journal article
- Published by Elsevier in Asia-Pacific Journal of Oncology Nursing
- Vol. 12, 100691
Abstract
No abstract availableKeywords
Funding Information
- Capital Medical University (SZHL23Q08)
- Capital Medical University (SZHL23Q01)
- National Key Research and Development Program of China (2017YFC1309204)
- Natural Science Foundation of Beijing Municipality
This publication has 57 references indexed in Scilit:
- Epidemiology of Cancer-Associated Venous Thromboembolism in Patients With Solid and Hematologic Neoplasms in the Veterans Affairs Health Care SystemJAMA Network Open, 2023
- Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With CancerJAMA Network Open, 2023
- Minimum sample size for external validation of a clinical prediction model with a binary outcomeStatistics in Medicine, 2021
- D-Dimer Enhances Risk-Targeted Thromboprophylaxis in Ambulatory Patients with CancerThe Oncologist, 2020
- Estimating a time‐dependent concordance index for survival prediction models with covariate dependent censoringStatistics in Medicine, 2012
- Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patientsCancer, 2007
- Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyondStatistics in Medicine, 2007
- Assessment and comparison of prognostic classification schemes for survival dataStatistics in Medicine, 1999
- MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORSStatistics in Medicine, 1996
- Survival analysis and neural netsStatistics in Medicine, 1994